SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000850693-11-000005
Filing Date
2011-08-03
Accepted
2011-08-03 16:49:35
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 2009186
2 EXHIBIT 10.1 dex101.htm EX-10.1 45564
3 EXHIBIT 10.2 dex102.htm EX-10.2 44326
4 EXHIBIT 31.1 dex311.htm EX-31.1 14202
5 EXHIBIT 31.2 dex312.htm EX-31.2 14117
6 EXHIBIT 32 dex32.htm EX-32 14427
  Complete submission text file 0000850693-11-000005.txt   10481022

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT agn-20110630.xml EX-101.INS 1827603
8 XBRL TAXONOMY EXTENSION SCHEMA agn-20110630.xsd EX-101.SCH 67662
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agn-20110630_cal.xml EX-101.CAL 101144
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agn-20110630_def.xml EX-101.DEF 207980
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE agn-20110630_lab.xml EX-101.LAB 793087
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agn-20110630_pre.xml EX-101.PRE 386694
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10269 | Film No.: 111007469
SIC: 2834 Pharmaceutical Preparations